Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Wellspring Longevity Clinic

Two GLP-1 desks, one scoreboard. We put CoreAge Rx and Wellspring Longevity Clinic head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 484 · Grade C

Wellspring Longevity Clinic

Visit Wellspring Longevity Clinic Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 47 on our six-factor Brief Score — The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

That doesn't make Wellspring Longevity Clinic a bad call — it's best for readers who want longevity-minded shoppers wanting compounded glp-1 alongside nad+, peptides, and microdosing. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 on the board — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
69
Transparency
90
20
Access Breadth
93
30
Clinical Oversight
92
73
Track Record
88
60
CoreAge RxBrief Score 94 · 47Wellspring Longevity Clinic

Price, coverage & the tracker

CoreAge RxWellspring Longevity Clinic
Brief Score94/100 (A)47/100 (C)
Semaglutide$149/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.

Wellspring Longevity Clinic: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.